GMMMG holds open consultations on decisions which affect patient care. This may include updated formulary chapters, new or updated clinical guidelines or commissioning statements, or changes to formulary status. All comments received are carefully considered by the group which made the decision, before a final recommendation is made. Decisions are then reviewed by GMMMG for information or approval, as appropriate.
Consultations typically run for six weeks, and comments are invited from all stakeholders across Greater Manchester. You can comment on current proposals via the links in the table below.
Please direct any questions to the secretariat at email@example.com.
GMMMG Clinical Reference Group proposed actions from April 2023
[link removed - consultation closed]
|On behalf of the GMMMG Clinical Reference Group, we now seek comments on the actions proposed at the April 2023 CRG meeting. This consultation period is open until 5pm on Thursday 1st June 2023.||[link removed - consultation closed]||June 1st, 2023|
|GM hypertension pathway||The Greater Manchester Strategic Clinical Network (SCN) have developed an Adult Hypertension Medication Pathway for use in GM. The consultation will run until 5pm on Tuesday 6th June 2023.||Feedback Form||June 6th, 2023|
|GM long-term azithromycin in adults with chronic respiratory disease||Following development in Bury and adaptation for implementation across the ICB, we now seek comments on draft guidance for long-term azithromycin for chronic respiratory conditions. The consultation will run until 5pm on Wednesday 7th June 2023.||Feedback Form||June 7th, 2023|
|GMMMG Clinical Reference Group proposed actions from May 2023||On behalf of the GMMMG Clinical Reference Group, we now seek comments on the actions proposed at the April 2023 CRG meeting. This consultation period is open until 5pm on Friday 23rd June 2023.||Feedback Form||June 23rd, 2023|